קרוודילול טבע    6.25 מג Israel - Tiếng Do Thái - Ministry of Health

קרוודילול טבע 6.25 מג

teva israel ltd - carvedilol - טבליה - carvedilol 6.25 mg - carvedilol - carvedilol - treatment of symptomatic congestive heart failure. carvedilol teva may be used as adjunct to standard therapy, but may also be used in those patients unable to tolerate an ace inhibitor, or those who are not receiving digitalis, hydralazine or nitrate therapy.

קרוודילול טבע   12.5 מג Israel - Tiếng Do Thái - Ministry of Health

קרוודילול טבע 12.5 מג

teva israel ltd - carvedilol - טבליה - carvedilol 12.5 mg - carvedilol - carvedilol - treatment of symptomatic congestive heart failure. carvedilol teva may be used as adjunct to standard therapy, but may also be used in those patients unable to tolerate an ace inhibitor, or those who are not receiving digitalis, hydralazine or nitrate therapy.

קרוודילול טבע ® 12.5 מ"ג Israel - Tiếng Do Thái - Ministry of Health

קרוודילול טבע ® 12.5 מ"ג

teva pharmaceutical indust.ltd - carvedilol 12.5 mg - tablets - carvedilol - treatment of symptomatic congestive heart failure. carvedilol teva may be used as adjunct to standard therapy, but may also be used in those patients unable to tolerate an ace inhibitor, or those who are not receiving digitalis, hydralazine or nitrate therapy.

אטקנד  4 מג Israel - Tiếng Do Thái - Ministry of Health

אטקנד 4 מג

tzamal bio-pharma ltd - candesartan cilexetil - טבליה - candesartan cilexetil 4 mg - candesartan - candesartan - hypertension. treatment of patients with heart failure and impaired left ventricle systolic function ( left ventricular ejection fraction < or = 40 % ) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

אטקנד   8 מג Israel - Tiếng Do Thái - Ministry of Health

אטקנד 8 מג

tzamal bio-pharma ltd - candesartan cilexetil - טבליה - candesartan cilexetil 8 mg - candesartan - candesartan - hypertension. treatment of patients with heart failure and impaired left ventricle systolic function ( left ventricular ejection fraction < or = 40 % ) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

אטקנד  16 מג Israel - Tiếng Do Thái - Ministry of Health

אטקנד 16 מג

tzamal bio-pharma ltd - candesartan cilexetil - טבליה - candesartan cilexetil 16 mg - candesartan - candesartan - hypertension. treatment of patients with heart failure and impaired left ventricle systolic function ( left ventricular ejection fraction < or = 40 % ) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

קנדור 16 Israel - Tiếng Do Thái - Ministry of Health

קנדור 16

unipharm ltd, israel - candesartan cilexetil - טבליה - candesartan cilexetil 16 mg - candesartan - candesartan - hypertension. treatment of patients with heart failure and impaired left ventricle systolic function (left ventricular ejection fraction < or = 40 % ) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated

קנדור 8 Israel - Tiếng Do Thái - Ministry of Health

קנדור 8

unipharm ltd, israel - candesartan cilexetil - טבליה - candesartan cilexetil 8 mg - candesartan - candesartan - hypertension. treatment of patients with heart failure and impaired left ventricle systolic function (left ventricular ejection fraction < or = 40 % ) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated

סומאברט 10 מג Israel - Tiếng Do Thái - Ministry of Health

סומאברט 10 מג

pfizer pharmaceuticals israel ltd - pegvisomant - אבקה וממס להכנת תמיסה להזרקה - pegvisomant 10 mg - pegvisomant - pegvisomant - treatment of patient with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalize igf-i concentrations or was not tolerated.

סומאברט 15 מג Israel - Tiếng Do Thái - Ministry of Health

סומאברט 15 מג

pfizer pharmaceuticals israel ltd - pegvisomant - אבקה וממס להכנת תמיסה להזרקה - pegvisomant 15 mg - pegvisomant - pegvisomant - treatment of patient with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not narmalize igf-i concentrations or was not tolerated.